Achieve Life Sciences Inc (NASDAQ:ACHV) hit a new 52-week low during trading on Wednesday . The company traded as low as $1.85 and last traded at $1.93, with a volume of 6655 shares. The stock had previously closed at $2.05.
Separately, LADENBURG THALM/SH SH initiated coverage on shares of Achieve Life Sciences in a report on Monday, August 20th. They set a “buy” rating and a $12.00 price target for the company.
The firm has a market capitalization of $9.88 million, a P/E ratio of -0.09 and a beta of 1.88.
About Achieve Life Sciences (NASDAQ:ACHV)
Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms.
Featured Article: What are retained earnings?
Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.